Dayong Quan Selected Research

Secondary Hyperparathyroidism

1/2013

Meta-analysis: the efficacy and safety of paricalcitol for the treatment of secondary hyperparathyroidism and proteinuria in chronic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dayong Quan Research Topics

Disease

1	Hypercalcemia (Milk Alkali Syndrome) 01/2013
1	Secondary Hyperparathyroidism 01/2013
1	Proteinuria 01/2013
1	Chronic Renal Insufficiency 01/2013
1	Vascular Calcification 01/2013

Drug/Important Bio-Agent (IBA)

1	calcium phosphateIBA 01/2013
1	paricalcitol (Zemplar)FDA Link 01/2013
1	Vitamin D FDA LinkGeneric 01/2013